Live Chat

Trade Bristol Myers BMY

BristolMyers live chart

instrument_fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) instr__open High Low

News

Info

Spread

0.33

Spread (%)

0.6312 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

106397949952

instr__shares_outstand

2027399936

instr__earnings_date

2001-08-07

Div Yield

2024-11-01

Ex-Dividend Date 

2024-10-04

Forward annual dividend rate

2.4

Forward annual dividend yield

0.0449

instr__eps

-3.25

instrument_learn_more

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

related_instruments

Asset
Sell
Buy
Change (%)
view_all_instruments

Markets.com news

Keep up with the news as it happens and know what’s impacting the markets at any time.

Wall Street's leading indices notch fresh records ahead of US inflation data release later today

Thursday, 10 October 2024

Wall St. soars to new highs ahead of US inflation report

Wednesday, 9 October 2024

Hang Seng index surges, breaking 21,000 mark

Wednesday, 9 October 2024

Dow Jones index today: Dow Hit Record Closing Highs

Wednesday, 9 October 2024

Nvidia stock surges 4% in Tuesday, notching its fifth straight day of gains

Live Chat